{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:14:36Z","timestamp":1791983676637,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,3,31]],"date-time":"2009-03-31T00:00:00Z","timestamp":1238457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2009,3,31]],"date-time":"2009-03-31T00:00:00Z","timestamp":1238457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The present study was conducted to determine whether patients with polymyalgia rheumatica (PMR) are at an increased risk of peripheral arterial disease (PAD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An inception cohort of all Olmsted County, Minnesota residents diagnosed with PMR between 1 January 1970 and 31 December 1999 was compared with non-PMR subjects (two for each PMR subject) from among residents. Both cohorts were followed longitudinally by complete medical record review from the incidence date of PMR (or index date for the non-PMR cohort) until death, incident PAD, migration, or 31 December 2006. PMR-related disease characteristics, traditional cardiovascular risk factors and diagnosis of PAD were abstracted from the medical record. Cumulative incidence of PAD was estimated using Kaplan\u2013Meier methods. Cox proportional hazards models were used to assess the risk of PAD in PMR compared with non-PMR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 353 PMR patients (mean age 73.3 years, 67% women) and 705 non-PMR subjects (mean age 73.2 years, 68% female) were followed for a median of 11.0 years. PAD developed in 38 patients (10-year cumulative incidence, 8.5%) with PMR and in 28 non-PMR subjects (10-year cumulative incidence, 4.1%) (hazard ratio (95% confidence interval), 2.40 (1.47, 3.92)). After adjusting for traditional cardiovascular risk factors, patients with PMR still had a significantly higher risk for PAD (hazard ratio, 2.50 (1.53, 4.08)) compared with controls. Giant cell arteritis occurred in 63 (18%) PMR patients but was not predictive of PAD (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.15). There was no difference between mortality in PMR and the non-PMR cohorts nor in PMR patients with and those without PAD (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.16).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with PMR appear to have an increased risk of PAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/ar2664","type":"journal-article","created":{"date-parts":[[2009,3,31]],"date-time":"2009-03-31T14:14:27Z","timestamp":1238508867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study"],"prefix":"10.1186","volume":"11","author":[{"given":"Kenneth J","family":"Warrington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena P","family":"Jarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie T","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene G","family":"Hunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine E","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,31]]},"reference":[{"key":"2505_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1056\/NEJMra011913","volume":"347","author":"C Salvarani","year":"2002","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG: Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002, 347: 261-271. 10.1056\/NEJMra011913.","journal-title":"N Engl J Med"},{"key":"2505_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.berh.2004.06.003","volume":"18","author":"C Salvarani","year":"2004","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG: Polymyalgia rheumatica. Best Pract Res Clin Rheumatol. 2004, 18: 705-722. 10.1016\/j.berh.2004.06.003.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2505_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7326\/0003-4819-139-6-200309160-00015","volume":"139","author":"CM Weyand","year":"2003","unstructured":"Weyand CM, Goronzy JJ: Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med. 2003, 139: 505-515.","journal-title":"Ann Intern Med"},{"key":"2505_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMra022694","volume":"349","author":"CM Weyand","year":"2003","unstructured":"Weyand CM, Goronzy JJ: Medium- and large-vessel vasculitis. N Engl J Med. 2003, 349: 160-169. 10.1056\/NEJMra022694.","journal-title":"N Engl J Med"},{"key":"2505_CR5","first-page":"65","volume":"32","author":"HM Kremers","year":"2005","unstructured":"Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE: Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheumatol. 2005, 32: 65-73.","journal-title":"J Rheumatol"},{"key":"2505_CR6","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMoa035471","volume":"349","author":"MJ Roman","year":"2003","unstructured":"Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE: Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003, 349: 2399-2406. 10.1056\/NEJMoa035471.","journal-title":"N Engl J Med"},{"key":"2505_CR7","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/art.10089","volume":"46","author":"S Van Doornum","year":"2002","unstructured":"Van Doornum S, McColl G, Wicks IP: Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?. Arthritis Rheum. 2002, 46: 862-873. 10.1002\/art.10089.","journal-title":"Arthritis Rheum"},{"key":"2505_CR8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/art.20878","volume":"52","author":"H Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE: Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005, 52: 722-732. 10.1002\/art.20878.","journal-title":"Arthritis Rheum"},{"key":"2505_CR9","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/art.21311","volume":"53","author":"HM Kremers","year":"2005","unstructured":"Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE: Direct medical costs of polymyalgia rheumatica. Arthritis Rheum. 2005, 53: 578-584. 10.1002\/art.21311.","journal-title":"Arthritis Rheum"},{"key":"2505_CR10","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","volume":"110","author":"E Selvin","year":"2004","unstructured":"Selvin E, Erlinger TP: Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999\u20132000. Circulation. 2004, 110: 738-743. 10.1161\/01.CIR.0000137913.26087.F0.","journal-title":"Circulation"},{"key":"2505_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/01.CIR.96.1.44","volume":"96","author":"JM Murabito","year":"1997","unstructured":"Murabito JM, D'Agostino RB, Silbershatz H, Wilson PWF: Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation. 1997, 96: 44-49.","journal-title":"Circulation"},{"key":"2505_CR12","first-page":"1694","volume":"29","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE: Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol. 2002, 29: 1694-1697.","journal-title":"J Rheumatol"},{"key":"2505_CR13","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, et al: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990, 33: 1122-1128.","journal-title":"Arthritis Rheum"},{"key":"2505_CR14","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.1161\/01.CIR.101.1.e16","volume":"101","author":"P Greenland","year":"2000","unstructured":"Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, Crouse JR, Friedman L, Fuster V, Herrington DM, Kuller LH, Ridker PM, Roberts WC, Stanford W, Stone N, Swan HJ, Taubert KA, Wexler L: Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000, 101: E16-E22.","journal-title":"Circulation"},{"key":"2505_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/CIRCULATIONAHA.105.593442","volume":"114","author":"BA Golomb","year":"2006","unstructured":"Golomb BA, Dang TT, Criqui MH: Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006, 114: 688-699. 10.1161\/CIRCULATIONAHA.105.593442.","journal-title":"Circulation"},{"key":"2505_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53: 457-481. 10.2307\/2281868.","journal-title":"J Am Stat Assoc"},{"key":"2505_CR17","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/art.21628","volume":"54","author":"KP Liang","year":"2006","unstructured":"Liang KP, Liang KV, Matteson EL, McClelland RL, Christianson TJ, Turesson C: Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis Rheum. 2006, 54: 642-648. 10.1002\/art.21628.","journal-title":"Arthritis Rheum"},{"key":"2505_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","volume":"97","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998, 97: 425-428.","journal-title":"Circulation"},{"key":"2505_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jvs.2005.12.051","volume":"43","author":"SE Musicant","year":"2006","unstructured":"Musicant SE, Taylor LM, Peters D, Schuff RA, Urankar R, Landry GJ, Moneta GL: Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease. J Vasc Surg. 2006, 43: 772-780. 10.1016\/j.jvs.2005.12.051. discussion 780.","journal-title":"J Vasc Surg"},{"key":"2505_CR20","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1161\/CIRCULATIONAHA.105.608679","volume":"113","author":"V Aboyans","year":"2006","unstructured":"Aboyans V, Criqui MH, Denenberg JO, Knoke JD, Ridker PM, Fronek A: Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation. 2006, 113: 2623-2629. 10.1161\/CIRCULATIONAHA.105.608679.","journal-title":"Circulation"},{"key":"2505_CR21","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1161\/01.CIR.0000074227.53616.CC","volume":"107","author":"MM McDermott","year":"2003","unstructured":"McDermott MM, Greenland P, Green D, Guralnik JM, Criqui MH, Liu K, Chan C, Pearce WH, Taylor L, Ridker PM, Schneider JR, Martin G, Rifai N, Quann M, Fornage M: D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation. 2003, 107: 3191-3198. 10.1161\/01.CIR.0000074227.53616.CC.","journal-title":"Circulation"},{"key":"2505_CR22","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.amjcard.2005.07.041","volume":"96","author":"JA Beckman","year":"2005","unstructured":"Beckman JA, Preis O, Ridker PM, Gerhard-Herman M: Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol. 2005, 96: 1374-1378. 10.1016\/j.amjcard.2005.07.041.","journal-title":"Am J Cardiol"},{"key":"2505_CR23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/art.20231","volume":"51","author":"MA Gonzalez-Gay","year":"2004","unstructured":"Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J: Giant cell arteritis without clinically evident vascular involvement in a defined population. Arthritis Rheum. 2004, 51: 274-277. 10.1002\/art.20231.","journal-title":"Arthritis Rheum"},{"key":"2505_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","volume":"121","author":"CM Weyand","year":"1994","unstructured":"Weyand CM, Hicok KC, Hunder GG, Goronzy JJ: Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 1994, 121: 484-491.","journal-title":"Ann Intern Med"},{"key":"2505_CR25","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1172\/JCI117428","volume":"94","author":"AD Wagner","year":"1994","unstructured":"Wagner AD, Goronzy JJ, Weyand CM: Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. J Clin Invest. 1994, 94: 1134-1140. 10.1172\/JCI117428.","journal-title":"J Clin Invest"},{"key":"2505_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/rheumatology\/38.5.444","volume":"38","author":"D Blockmans","year":"1999","unstructured":"Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, Bobbaers H, Mortelmans L: New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford, England). 1999, 38: 444-447. 10.1093\/rheumatology\/38.5.444.","journal-title":"Rheumatology (Oxford, England)"},{"key":"2505_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","volume":"46","author":"D Blockmans","year":"2007","unstructured":"Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H: Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford). 2007, 46: 672-677. 10.1093\/rheumatology\/kel376.","journal-title":"Rheumatology (Oxford)"},{"key":"2505_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/scientificamerican1081-54","volume":"245","author":"LT Kurland","year":"1981","unstructured":"Kurland LT, Molgaard CA: The patient record in epidemiology. Sci Am. 1981, 245: 54-63.","journal-title":"Sci Am"},{"key":"2505_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4065\/71.3.266","volume":"71","author":"LJ Melton 3rd","year":"1996","unstructured":"Melton LJ: History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996, 71: 266-274. 10.4065\/71.3.266.","journal-title":"Mayo Clin Proc"},{"key":"2505_CR30","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.rdc.2004.07.010","volume":"30","author":"H Maradit Kremers","year":"2004","unstructured":"Maradit Kremers H, Crowson CS, Gabriel SE: Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am. 2004, 30: 819-834. 10.1016\/j.rdc.2004.07.010. vii.","journal-title":"Rheum Dis Clin North Am"},{"key":"2505_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/art.22548","volume":"57","author":"H Maradit Kremers","year":"2007","unstructured":"Maradit Kremers H, Reinalda MS, Crowson CS, Davis JM, Hunder GG, Gabriel SE: Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum. 2007, 57: 279-286. 10.1002\/art.22548.","journal-title":"Arthritis Rheum"},{"key":"2505_CR32","unstructured":"National Centre for Research Resources. [http:\/\/www.ncrr.nih.gov]"},{"key":"2505_CR33","unstructured":"NIH Roadmap for Medical Research. [http:\/\/www.nihroadmap.nih.gov]"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2664.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2664\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2664.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T07:10:32Z","timestamp":1728371432000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,31]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,4]]}},"alternative-id":["2505"],"URL":"https:\/\/doi.org\/10.1186\/ar2664","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1162777.624375","asserted-by":"object"}]},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,31]]},"assertion":[{"value":"13 December 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R50"}}